A carregar...
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
Parkinson’s disease therapy is still focused on the use of L-3,4-dihydroxyphenylalanine (levodopa or L-dopa) for the symptomatic treatment of the main clinical features of the disease, despite intensive pharmacological research in the last few decades. However, regardless of its effectiveness, the l...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3808152/ https://ncbi.nlm.nih.gov/pubmed/24174877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S36693 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|